医学
利拉鲁肽
减肥
不利影响
艾塞那肽
赛马鲁肽
2型糖尿病
低血糖
恶心
糖尿病
呕吐
重症监护医学
内科学
胰岛素
内分泌学
肥胖
作者
Brit Long,Jessica Pelletier,Alex Koyfman,Rachel E. Bridwell
标识
DOI：10.1016/j.ajem.2024.01.010
摘要
Glucagon-like peptide 1 (GLP-1) based therapies, including GLP-1 agonists, are currently in use for treatment of diabetes and obesity. However, several complications may occur with their use.
科研通智能强力驱动
Strongly Powered by AbleSci AI
tianzml0
不配.
吃不饱星球球长
含蓄的明雪
彭于彦祖
苏卿
薰硝壤
哎嘿
pcr163
甜甜玫瑰
Singularity
暮霭沉沉
互助遵法尚德
iNk
从容芮
Henry
遥远的尧
Frank
oceanao
嗯哼
皖公网安备34019202002308
